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Signaling mechanisms used by Haemophilus influenzae to adapt to conditions it encounters during stages of
infection and pathogenesis are not well understood. The ArcAB two-component signal transduction system
controls gene expression in response to respiratory conditions of growth and contributes to resistance to
bactericidal effects of serum and to bloodstream infection by H. influenzae. We show that ArcA of nontypeable
H. influenzae (NTHI) activates expression of a glycosyltransferase gene, lic2B. Structural comparison of the
lipooligosaccharide (LOS) of a lic2B mutant to that of the wild-type strain NT127 revealed that lic2B is
required for addition of a galactose residue to the LOS outer core. The lic2B gene was crucial for optimal
survival of NTHI in a mouse model of bacteremia and for evasion of serum complement. The results demon-
strate that ArcA, which controls cellular metabolism in response to environmental reduction and oxidation
(redox) conditions, also coordinately controls genes that are critical for immune evasion, providing evidence
that NTHI integrates redox signals to regulate specific countermeasures against host defense.
Haemophilus influenzae is a Gram-negative bacterium that
colonizes the human nasopharyngeal mucosa and can dissem-
inate to other sites to cause otitis media, upper and lower
respiratory tract infections, septicemia, and meningitis (37, 50).
It frequently infects the lungs of individuals with chronic ob-
structive pulmonary disease (51, 52, 65) and cystic fibrosis (20,
49). The introduction in 1990 of an effective vaccine against the
capsular polysaccharide of encapsulated H. influenzae type b
(Hib) strains has decreased the incidence of systemic infections
caused by Hib strains in developed countries (9). However, the
vaccine is not effective against nonencapsulated, nontypeable
H. influenzae (NTHI). NTHI predominantly causes respiratory
tract infections and otitis media but occasionally can enter the
bloodstream to cause meningitis (11, 15, 54, 55). Prior to in-
troduction of the Hib vaccine, NTHI was not a major cause of
invasive disease; however, in the post-Hib vaccine era, the
incidence of invasive infections due to NTHI has increased and
is shifting from infants to older populations (14, 68).
The factors contributing to invasive disease, likely involving
host susceptibility and strain-specific virulence genes, are not
well understood. A correlation was observed between disease
severity during invasive NTHI infections (bacteremia or men-
ingitis) and the degree of resistance of the corresponding
NTHI isolate to bactericidal effects of human serum in vitro,
suggesting that increased resistance to complement enhances
virulence (23). The complement system plays an important role
in adaptive and innate immune defenses against H. influenzae
infection in both humans and animal models (16, 17, 59, 72,
74). Three major pathways, i.e., classical, lectin, and alterna-
tive, that differ in their mode of activation on the pathogen
surface (60, 72) can initiate complement deposition. Each
pathway involves a cascade of proteolytic cleavage steps that
activate subsequent factors, leading to antimicrobial activities
that include target cell lysis, inflammation, opsonization-pro-
moting phagocytosis, and activation of the bactericidal mech-
anisms of macrophages and neutrophils.
The lipopolysaccharide (LPS) glycolipid of the outer leaflet
of the Gram-negative bacterial outer membrane mediates eva-
sion of the complement system and is essential in animal mod-
els of invasive infection by H. influenzae (7, 16, 29, 41). In
H. influenzae and in many other human respiratory tract patho-
gens, the LPS is termed lipooligosaccharide (LOS) because it
lacks the repetitive polysaccharide O-antigen side chain pres-
ent in the LPS of other Gram-negative bacteria (50). The LOS
structure varies between strains, yet several features are con-
served. H. influenzae LOS consists of lipid A, an inner core
usually composed of a single 3-deoxy-D-manno-octulosonic
acid linked to three heptose residues, and an outer core usually
containing a short heteropolymer of glucose and galactose
residues in different configurations extending from the hepto-
syl residues of the inner core. The outer core may additionally
be modified with sialic acid, N-acetylgalactosamine, and phos-
phorylcholine (31, 62).
During pathogenesis, bacteria sense and respond to environ-
mental signals to appropriately express critical virulence fac-
tors or to repress those that would otherwise detract from
efficient infection, such as structures recognized by host im-
mune pathways. H. influenzae has been shown to modify its
LOS in response to environmental aeration conditions by in-
creasing levels of phosphorylcholine displayed on the LOS
outer core as oxygen levels decrease (75), a response that may
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allow NTHI to differentially express LOS structures for eva-
sion of immune effectors present in environments in the host
such as airway mucosal surfaces versus invasion into deeper
tissues or in the bloodstream. Mechanisms by which H. influ-
enzae senses and responds to such reduction/oxidation (redox)
signals to regulate LOS synthesis have not been identified;
however, H. influenzae possesses a redox-responsive regulatory
system, the ArcAB two-component signaling system (TCS),
that is biochemically and functionally similar to that of Esch-
erichia coli (19, 44). Under low-oxygen conditions, ArcB senses
the redox status of the quinone pool and autophosphorylates,
leading to activation of ArcA by phosphoryl transfer (4, 18,
43). Phosphorylated ArcA transcriptionally activates or represses
diverse target genes, including genes of the tricarboxylic acid
cycle and genes involved in other aspects of respiratory or
fermentative metabolism (12, 39, 40, 77). Under high-oxygen
conditions, ArcAB activity is greatly decreased. In H. influen-
zae, ArcA has been demonstrated to be important for serum
resistance and pathogenesis in mouse models of bacteremia
(12, 77); however, ArcA-regulated virulence genes have not
been identified, and the mechanism of ArcA-mediated serum
resistance is unknown.
In the current study, we investigated mechanisms by which
the H. influenzae ArcAB two-component signaling system influ-
ences NTHI pathogenesis. Strain-specific differences in ArcA-
dependent serum resistance led us to investigate whether ArcA-
regulated LOS genes unique to invasive strains are involved in
this virulence phenotype. We found that ArcAB controls ex-
pression of genes involved in the production of the outer core
of the LOS, lic2B and lic2C, in NTHI strains. The LOS struc-
ture specified by Lic2B and its role in inhibition of complement
interactions were characterized to provide insight into the mo-
lecular mechanism of NTHI pathogenesis. Together the results
indicate that the redox-responsive ArcA regulator controls
transcription of LOS glycosyltransferase genes that are impor-
tant for pathogenesis and evasion of complement, suggesting
that H. influenzae utilizes redox signaling to appropriately
modify its immune evasion strategies in different environments
encountered during infection.
MATERIALS AND METHODS
Media and Haemophilus influenzae growth conditions. The nontypeable Hae-
mophilus influenzae (NTHI) clinical isolates NT127 and PittGG were grown at
35°C  1.5°C in brain heart infusion supplemented with 10 g/ml NAD and 10
g/ml hemin (sBHI) on agar plates or in sBHI broth cultures. NT127 was
isolated from the blood of a 6-month-old patient with meningitis (provided by
Robert N. Husson) (25), and its genome has been sequenced (GenBank acces-
sion no. ACSL00000000.1). PittGG (provided by Garth D. Ehrlich), which also
has been sequenced (GenBank accession no. CP000672.1), was isolated from the
external ear discharge of a child with otorrhea (7, 66). DNA was transformed
into naturally competent H. influenzae prepared as previously described (3).
Kanamycin (Km), gentamicin (Gm), and tetracycline (Tet) were added to sBHI
at 20 g/ml, 10 g/ml, and 8 g/ml, respectively.
Plasmid and H. influenzae strain construction. Standard molecular biology
methods were used for plasmid construction (2). All primer sequences are listed
in Table 1. Strains and plasmids used in this study are listed in Table 2. An arcA
mutation in NT127 was created by amplification of a 3.56-kb PCR product using
primers ArcA2466 and ArcA5582 from H. influenzae Rd strain RAA6, which
contains a nonpolar, in-frame deletion of the arcA protein-coding sequences
(19), and transformation of NT127 with the resulting product. Kmr transfor-
mants were selected on sBHI agar containing Km to create the arcA deletion
strain NTAA. Strains NT127V and NTAAV, containing empty vector sequences
at the partial xyl locus, were generated as follows. A 1.4-kb PCR product was
amplified from NT127 with primers JbaspC2-Pci and xylAorfout, and an 6.8-kb
PCR product was amplified from pXT10 (76) with primers tetR-in1 and xylB-
3ORF3. These two products were used as templates in a PCR stitching reaction
to generate a 8.2-kb PCR product for transformation into NT127 and NTAA.
Tetr transformants undergoing homologous recombination between the 8.2-kb
product at aspC2 and the xyl locus were selected on sBHI agar containing Tet. An
arcA complementing strain containing a wild-type copy of arcA in the xylA locus
was created as follows. The 1.4-kb PCR product described above and a 7.73-kb
PCR product amplified from pXTAA (19) with primers AAtetR-in1 and xylB-
3ORF3 were used as templates in a PCR stitching reaction to generate a 9.1-kb
PCR product used for transformation into NTAA. Tetr transformants were
selected on sBHI agar containing Tet to create the arcA complementing strain
NTAAC. Nonpolar, in-frame deletion mutations of lic2B in NT127 were created
by replacement of the protein-coding sequences with the aacC1 gentamicin
resistance cassette to create NTlic2B by PCR stitching as follows. A 1,023-bp
PCR product containing the 5 flanking region of lic2B was amplified from
NT127 with primers 1kb5JBlic2B and JBlic2B-5out. A 1,030-bp PCR product
containing the 3 flanking region of lic2B was amplified from NT127 with primers
JBlic2B-3out and 1kb3JBlic2B. A 536-bp fragment containing the aacC1 gen-
tamicin resistance gene was amplified with primers aacC15 and aacC13 from
pBSL182 (1). The 1023-bp, 1030-bp, and 536-bp products were stitched in a PCR
with primers 1kb5JBlic2B and 1kb3JBlic2B. The resultant 2,559-bp product was
introduced into three independent cultures of NT127, and Gmr transformants
were selected on sBHI agar containing Gm to create independent isolates of
strain NTlic2B containing a precise replacement of the lic2B coding sequence
with those of aacC1. Similarly, a lic2B deletion mutation in PittGG was created
by transforming this strain with the same 2,559-bp PCR product (see above) and
selecting for Gmr transformants on sBHI agar containing Gm to create strain
PittGGlic2B.
A nonpolar, in-frame deletion of lic2C in NT127 was created by replacement
of the protein-coding sequences with the aacC1 gentamicin resistance cassette to
create NTlic2C by PCR stitching as follows. A 1,023-bp PCR product containing
the 5 flanking region of lic2C was amplified from NT127 with primers
1kb5JBlic2C and JBlic2C-5out. A 1,036-bp PCR product containing the 3
flanking region of lic2C was amplified from NT127 with primers JBlic2C-3out
and 1kb3JBlic2C. The 1,023-bp, 1,036-bp, and 536-bp products containing the
aacC1 gentamicin resistance cassette (see above) were combined by sequence
overlap extension PCR with primers 1kb5JBlic2C and 1kb3JBlic2C. The resul-
tant 2,565-bp product was introduced into NT127, and Gmr transformants were
selected on sBHI agar containing Gm to create strain NTlic2C.
A nonpolar, in-frame deletion of lex2A in NT127 was created by replacement
of the protein-coding sequences with a kanamycin resistance gene to create
NTlex2A by PCR stitching as follows. A 1,019-bp PCR product containing the 5
flanking region of lex2A was amplified from NT127 with primers 1kb5JBlex2A
and JBlex2A-5out. A 1,025-bp PCR product containing the 3 flanking region of
lex2A was amplified from NT127 with primers JBlex2A-3out and 1kb3JBlex2A.
An 818-bp fragment containing the kanamycin resistance gene aphI from Tn903
(76) was amplified with primers kan5ATG and kan3TAA. The 1,019-bp,
1,025-bp, and 818-bp products were combined in a PCR with primers
1kb5JBlex2A and 1kb3JBlex2A. The resultant 2,832-bp product was introduced
into NT127, and Kmr transformants were selected on sBHI agar containing Km
to create strain NTlex2A.
The lic2B-complemented strain NTlic2Bcomp was generated by using our
exchange vector pXT10 (76) containing the wild-type copy of lic2B for homol-
ogous recombination into the xyl locus. Briefly, a 1,081-bp product containing the
lic2B gene and its promoter region was amplified from NT127 with primers
lic2Bcomp5 and lic2Bcomp3. The 1,081-bp PCR product was digested with SapI
and cloned into the SapI sites of pXT10 to create plic2Bcomp. Because strain
NT127 lacks xylFGH, which are needed for recombination with pXT10, we
generated a Kmr-marked derivative of NT127 that contains the complete xyl
locus, as described previously (25), for subsequent transformation with pXT10
and its derivatives. The Kmr-marked NT127 derivative was transformed with the
2,559-bp PCR product containing the lic2B mutation (see above) to create a
lic2B mutant in this background. This resultant strain was then transformed with
pXT10 and the complementing plasmid, plic2Bcomp, to generate NTlic2BV and
NTlic2Bcomp, respectively. The Kmr-marked NT127 derivative was also trans-
formed with pXT10 to create a parent strain, NTV, carrying the empty cloning
vector (25). All strain constructions were verified by PCR amplification across
the inserted recombinant region with primers specific for flanking sequences.
Genes introduced for complementation of mutations were verified by DNA
sequence analysis.
Serum bactericidal assays. Serum bactericidal testing was performed as de-
scribed previously (48). Briefly 2,000 CFU of bacteria were grown anaerobi-
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cally (BD BBL GasPak Plus anaerobic system; Fisher Scientific) or aerobically
(10 ml in a 500-ml flask with shaking at 250 rpm) to mid-log phase and incubated
with or without normal human serum (NHS) (Innovative Research) at concen-
trations specified for each experiment in a final reaction mixture volume of 150
l. Dilutions of NHS-treated and untreated samples were plated on sBHI agar
plates at 0 and 30 min. In all cases, similar numbers of bacteria were recovered
from treated and untreated samples at 0 min. Survival was calculated as the ratio
of the number of CFU recovered at 30 min to the number of CFU recovered
from untreated samples. To isolate the role of the alternative pathway, 10 mM
EGTA and 10 mM MgCl2were added to NHS. Chelation of calcium by EGTA
and addition of MgCl2 selectively blocks the classical and lectin pathways but not
the alternative pathway (13, 57). Bactericidal assay with human C1q-depleted
serum (Quidel) was performed as described above to selectively block activation
of the classical pathway. To restore classical pathway activity to C1q-depleted
serum, purified human C1q (Complement Technology, Inc.) was added to a final
concentration of 100 g/ml. All experiments were conducted on triplicate inde-
pendent cultures.
Flow cytometry. Complement factors C3 and C4 and serum antibodies IgM
and IgG bound to bacteria were measured as described previously (42, 58).
Briefly, 108 CFU/ml of log-phase NT127 parent NTV, lic2B deletion mutant
NTlic2BV, and lic2B-complemented strain NTlic2BComp suspended in Hanks
balanced salt solution (HBSS) containing 0.15 mM CaCl2 and 1 mM MgCl2
(Invitrogen) were incubated with 5% pooled NHS in a final volume of 100 l and
incubated at 37°C for 30 min, followed by detection with fluorescein isothiocya-
nate (FITC)-conjugated polyclonal antibodies specific to C3c (Biodesign Int.,
Saco, ME), C4 (Abcam), IgM (Sigma), and IgG (Sigma).
Reverse transcriptase quantitative PCR (RT-qPCR). Quantification of rela-
tive mRNA expression of lic2B, lic2C, lex2A, lgtC, and rpoA from strains NT127,
NT127V, NTAA, NTAAV, NTAAC1, and NTAAC2 with RNA samples from
four independent cultures was performed using iQ SYBR green Supermix (Bio-
Rad Laboratories) in quantitative real-time PCR measured with the DNA En-
gine Opticon II system (MJ Research). Total RNA was obtained from cultures
grown anaerobically in sBHI to an optical density at 600 nm (OD600) of 0.2 to 0.4.
RNA was isolated using TRIzol reagent (Invitrogen), treated with DNase I
(Ambion), and phenol extracted. Briefly, 6 g of DNase I-treated total RNA
from the above-mentioned strains was used as the template in cDNA synthesis
using random primers (New England BioLabs) and SuperScript II reverse tran-
scriptase (Invitrogen). One-tenth of the reverse transcriptase reaction products
was used as the template in qPCR for amplification using 5 and 3 primer pairs
for lic2B (lic2B-5 and JBlic2Bint32), lic2C (JBlic2C-52 and JBlic2Cint32),
lex2A (JBlex2A-5rep and JBlex2A-3rep), lgtC (JBlgtC-5 and 258rep3-2), and
rpoA (HI0802-5 and JBrpoA 3). Genomic NT127 DNA ranging from 0.0001
ng to 100 ng was used as the template in the qPCRs with the same primer set to
generate a standard curve. Real-time cycler conditions were as follows: 95°C for
3 min; 39 cycles of 96°C for 20 s, 55°C for 30 s, and 72°C for 30 s; and one cycle
of 72°C for 7 min. Fluorescence was read at 72, 76, 78, 80, 81, and 82°C and
normalized to the housekeeping gene rpoA, which encodes the alpha subunit of
RNA polymerase. Control real-time PCRs performed in parallel with mock
cDNA reactions generated without reverse transcriptase to verify specific am-
plification yielded values below the level of detection. Product sizes were con-
firmed by agarose gel electrophoresis.
Primer extension analysis of NTHI mRNA. Briefly, 10 g of DNase I-treated
total RNA from wild-type NT127 was used as the template in a 20-l cDNA
synthesis reaction using 2 pmol of a 5 6-carboxyfluorescein (FAM)-labeled
primer, lic2BPE, located 70 bp 3 of the ATG initiation codon of lic2B and
SuperScript II reverse transcriptase (Invitrogen). Control reactions were per-
formed in parallel with mock cDNA reactions generated without reverse tran-
scriptase to verify specific amplification. DNA fragment analysis of the FAM-
labeled cDNAs was conducted at the University of Illinois at Urbana-Champaign
Sequencing Core using an ABI Prism 3730xl Analyzer with ROX 500 dye-labeled
size standards. Fragment sizes of the cDNA extension products were calculated
with Peak Scanner software (Applied Biosystems, Foster City, CA) with a reso-
lution of 2 bp.
TABLE 1. Oligonucleotides used in this study
Primer Sequence
JbaspC2-Pci..............................................................................................5AAAGATCTACATGTTAAACAAAACCCATTTTTGATTCG
xylAorfout ................................................................................................5CATAACATTTTCCTCTCTAGGTGA
tetR-in1 ....................................................................................................5GAGGAAAATGTTATGGCTCTTCGTAAGGATCCGAAATA
xylB-3ORF3 .............................................................................................5TTAATATAATTGTGATAAATGTGTTA
AAtetR-in1 ..............................................................................................5GAGGAAAATGTTATGGATGCTCGAAATTCTATCACAAAG
1kb5JBlic2B............................................................................................5ATTGACACACTGTGCCGATTAACG
JBlic2B-5out ...........................................................................................5GCTGCTGCGTAACATTTGGGGATCATGCTTATTGAGAAA
JBlic2B-3out ...........................................................................................5AGTACCGCCACCTAATCCAACATTATACTTTGATAAAGTAA
1kb3JBlic2B............................................................................................5ATTGGATTGAGAATACGGTGTAGC
aacC15.....................................................................................................5ATGTTACGCAGCAGCAACGATGTTACGCAGCAGG
aacC13.....................................................................................................5TTAGGTGGCGGTACTTGGGTCGAT
1kb5JBlic2C............................................................................................5CCATTGTATCCTCTAAAAATAATC
JBlic2C-5out ...........................................................................................5GCTGCTGCGTAACATATTTTTACTTTATCAAAGTATAATGTTG
JBlic2C-3out ...........................................................................................5AGTACCGCCACCTAATATTACCCATGACAGTTACACTAA
1kb3JBlic2C............................................................................................5AATGCAAGGTAAAGAAATTGTTCG
1kb5JBlex2A...........................................................................................5GAAGATATTACTGCGCCATTTATC
JBlex2A-5out..........................................................................................5TTGAATATGGCTCATAATTCCGCCTTCATAAAATATTTA
JBlex2A-3out..........................................................................................5GATGAGTTTTTCTAACTATGGAGAGATTATGTTTATTAC
1kb3JBlex2A...........................................................................................5CGATTGCAGTTTTACAAGCAGGAC
kan5ATG ..............................................................................................5ATGAGCCATATTCAACGGGAAAC
kan3TAA.............................................................................................5TTAGAAAAACTCATCGAGCATCAAA
lic2Bcomp5 ..............................................................................................5CGCGGATCCGCTCTTCAATGCGCGGAACATAGTATTCGGTAAAG
lic2Bcomp3 ..............................................................................................5CGCGGATCCGCTCTTCTTTATCTAAATGGTACTATGTGTTTAGAA
lic2B-5.......................................................................................................5ATGCATATAAATTACGTTATTAGTC
JBlic2Bint32 ...........................................................................................5TCATAAAACATGCTTTTTCTCCCTC
JBlic2C-52...............................................................................................5ACTAAATTAATAACAATTTCACTAAC
JBlic2Cint32 ...........................................................................................5CAAAAGAAAGATTAATCTTAATTGG
JBlex2A-5rep ...........................................................................................5AAATAAATATTTTATGAAGGCGGA
JBlex2A-3rep ...........................................................................................5AATATTGTTCTCTTTTCTTTTACC
JBlgtC-5 ..................................................................................................5AATCAGAGATAATTTCATGACAGA
258rep3-2..................................................................................................5CTAAAAATACTTACAGCTAAATAAGG
HI0802-5 .................................................................................................5GTAGAAATTGATGGCGTATTG
JBrpoA-3 ................................................................................................5CTGGATTTACAATTTCAACATCAC
lic2BPEa ...................................................................................................5TGAGAGAATTCTTTTTGAATATGC
a Labeled at the 5 end with 6-carboxyfluorescein (FAM).
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Murine bacteremia model. H. influenzae was grown to logarithmic phase
(OD600  0.3) as 20-ml cultures in 50-ml shake flasks at 35°C. Four-week-old
C57BL6 mice were inoculated by the intraperitoneal (i.p.) route at a dose of 2 
108 CFU of wild-type NT127 or its isogenic, nonpolar lic2B mutant NTlic2B
derivatives. For evaluating effects of the lic2B mutation, each mouse was inoc-
ulated with one of three lic2B deletion mutants generated in independent trans-
formations with the deletion construct as described above. Blood (5 l) was
collected by tail vein sampling at 4, 8, and 22 h postinfection and serially diluted
in BHI for CFU determination. Experiments were conducted with approval and
in accordance with guidelines of the University of Massachusetts Institutional
Animal Use and Care Committee.
Structural analysis of LOS. H. influenzae wild-type NT127 and lic2B mutant
NTlic2B were grown at 35°C to an OD600 of 1 to 2 for 15 h (with shaking at
80 rpm) in four 2,800-ml Fernbach flasks containing 2.5 liters of sBHI for a total
of 10 liters of culture per strain. Bacterial pellets were collected by centrifugation
followed by washing with 10 ml of HBSS and repelleted. Bacteria were killed by
phenol treatment (2% final concentration) for 3 h at room temperature with
gentle rotation followed by washing with 10 ml of water and repelleting for
lyophilization. LOS was isolated and purified as described previously (67).
Briefly, freeze-dried cells were washed with organic solvents (1 ethanol, 2
acetone, and 2 light petroleum ether) and extracted by the hot phenol-water
method. The aqueous phase was treated with DNase and RNase at 37°C for 4 h,
followed by proteinase K treatment at 37°C for 4 h, with the resulting small
peptides removed by dialysis. The retentate was freeze-dried and then brought to
a 2% solution in water and centrifuged at 8,000  g for 15 min. The supernatant
was removed, followed by centrifugation at 100,000  g for 5 h. The resulting
pellet from the high-speed centrifugation containing purified LOS was redis-
solved and freeze-dried. LOS samples were treated with anhydrous hydrazine
with stirring at 37°C for 1 h to prepare O-deacylated LOS (LOS-OH). The
reaction mixture was cooled in an ice bath, cold acetone (70°C, 5 volumes) was
gradually added to destroy excess hydrazine, and the precipitated LOS-OH was
isolated by centrifugation, redissolved in water, and lyophilized. The core oligo-
saccharides (OS) were isolated by treating the LOS with 1% acetic acid (10
mg/ml, 100°C, 1.5 h), with subsequent removal of the insoluble lipid A by
centrifugation (5,000  g). The lyophilized OS samples were subsequently fur-
ther purified on a Bio-Gel P-2 column and analyzed by capillary electrophoresis-
electrospray mass spectrometry (CE-ES-MS) and nuclear magnetic resonance
(NMR) spectroscopy as described previously (67). Sugars were determined as
their alditol acetate derivatives and linkage analysis conducted following meth-
ylation analysis by gas-liquid chromatography–mass spectrometry (GLC-MS) as
described previously (67).
Western blot analysis. H. influenzae strains were grown anaerobically to log-
arithmic phase (OD600  0.2 to 0.3) as 3-ml cultures at 35°C. A total of 108
bacteria suspended in HBSS containing 0.15 mM CaCl2 and 1 mM MgCl2 were
incubated with 5% pooled NHS in a final volume of 100 l for 30 min at 37°C.
Whole-cell lysates were separated by NuPAGE (Novex 4 to 12% Bis-Tris) and
immunoblotted with anti-iC3b monoclonal antibody (MAb) G-3E (a gift from
Kyoko Iida, University of Tsukuba, Japan) (32). Bound primary antibody was
visualized using the appropriate secondary antibodies conjugated to alkaline
phosphatase as described previously (6). As a loading control, the bottom third
of the same blot (proteins that migrated faster than 50 kDa) was stained with
Coomassie blue (CB). The ImageJ64 gel analysis image processing program
(http://rsbweb.nih.gov/ij/) was used to quantify the relative densities of bands in
the anti-iC3b Western blot and CB-stained gel. The relative density of total
intensity within bands ranging from 120 kDa to  67 kDa in sample lanes was
determined after subtracting the background area corresponding to the same size
range in the buffer-only control lane, followed by normalization to the relative
density of the 40-kDa band in the corresponding lane of the CB-stained portion
of the gel.
RESULTS
Based on the observation that arcA mutants of H. influenzae
type b were more sensitive than wild-type strains to killing by
human serum, it was previously postulated that ArcA-regu-
lated genes encoding cell surface structures may act as poten-
tial targets of humoral immune components in serum, such as
complement (12); however, such potential ArcA-regulated tar-
gets were not identified.
In contrast to the Hib study, our previous results detected no
difference in the serum resistances of an arcA mutant and the
wild type in the H. influenzae Rd strain background (77). Be-
cause LOS structure influences serum resistance levels and the
LOS outer core sugar extensions differ between H. influenzae
strains such as Rd (62) and Hib (46, 47), we postulated that
LOS structures found in pathogenic clinical isolates but absent
in Rd may account for the differential serum sensitivity be-
tween the arcA mutants of different strains. This hypothesis led
TABLE 2. Strains and plasmids used in this study
Strain or
plasmid Genotype and/or relevant features
Reference and/
or source
Strains
NT127 Nontypeable H. influenzae clinical isolate 26
PittGG Nontypeable H. influenzae clinical isolate G. Ehrlich (69)
NT127V NT127 xylA	4-802::tetAR; Tetr, empty cloning vector This study
NTAA NT127 	arcA::aphI; Kmr This study
NTAAV NT127 	arcA::aphI xylA	4-802::tetAR; arcA mutant carrying empty cloning vector sequence from
pXT10; Kmr Tetr
This study
NTAAC1 NT127 	arcA::aphI xylA	4-802::arcA; arcA mutant complemented with arcA expressed via arcA
promoter replacing xylA; Kmr Tetr
This study
NTAAC2 Same genotype as NTAAC1; isolate from an independent transformation This study
NTlic2B NT127 	lic2B::aacC1; Gmr This study
NTlic2C NT127 	lic2C::aacC1; Gmr This study
NTlex2A NT127 	lex2A:: aphI; Kmr This study
PittGGlic2B NT127 	lic2B::aacC1; Gmr This study
NTV NT127 xylA	4-802::tetAR; contains empty cloning vector sequence from pXT10; xylHGF introduced
into genome (see Materials and Methods); Tetr
26
NTlic2BV NTV 	lic2B::aacC1; lic2B mutant carrying empty cloning vector sequence from pXT10; Gmr Tetr This study
NTlic2BComp NT127 	lic2B::aacC1 xylA	4-802::lic2B; lic2B mutant containing lic2B complementing construct
(expressed via lic2B promoter) in the xyl locus, replacing xylA; Gmr Tetr
This study
Plasmids
pXT10 Delivery vector for chromosomal integration and expression at the xyl locus of H. influenzae;
contains xylF, xylB, xylA	4-802, and tetracycline resistance cassette; tetAR
80
plic2Bcomp pXT10 carrying lic2B expressed from lic2B promoter This study
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us to investigate a possible ArcA-mediated serum resistance
phenotype in NTHI and to address whether arcA-regulated
LOS biosynthesis genes participate in defense against comple-
ment-mediated killing. Transcriptional analysis of LOS genes
present in Hib and in pathogenic NTHI strains but absent in
Rd identified ArcA-mediated regulation of a putative LOS
glycosyltransferase gene, lic2B. The role of lic2B in LOS bio-
synthesis was then characterized by structural analysis of the
wild-type NTHI strain in comparison to a mutant in which
lic2B was deleted. Because complement resistance is an im-
portant factor in invasive infection (63), the role of lic2B was
then evaluated in a murine model of bacteremia. To obtain
insight into the molecular mechanisms of immune evasion by
NTHI, interactions of the lic2B mutant with specific comple-
ment components were assessed.
arcA is required for serum resistance and evasion of com-
plement by NTHI. To determine whether ArcA controls serum
resistance in NTHI, we tested the effect of a range of concen-
trations of normal human serum on the viability of an arcA
mutant derived from an NTHI clinical isolate, strain NT127.
Exposure of the anaerobically grown arcA mutant to 3% serum
resulted in 60% killing of the mutant but did not affect
viability of the parent, and survival was restored to near-pa-
rental levels in the arcA complemented strain (Fig. 1A). In
contrast, serum resistance of the aerobically grown arcA mu-
tant did not differ significantly from that of the parental strain
at this serum concentration (Fig. 1B), consistent with greater
activity of ArcA under low-oxygen conditions. That this differ-
ence was associated with a difference in complement binding
was supported by evidence that deletion of arcA resulted in
3-fold-increased binding to iC3b, a cleavage product of com-
plement component factor C3b, compared to that of the parent
(Fig. 1C, lanes 4 and 5 versus lanes 2 and 3) based on densi-
tometry of the region of the Western blot between 120 kDa
and 67 kDa (see Materials and Methods). The Western im-
munoblot analysis of iC3b associated with serum-treated bac-
terial samples revealed a “doublet” (67 kDa) in which the
upper band likely represents LOS covalently bound to the
iC3b
1 chain and the lower band the free (or “released”) iC3b

1 chain; the 
1 chain of iC3b bound to NTHI may undergo
additional cleavage that may account for its lower molecular
mass compared to that of purified soluble iC3b
1 chain (lane
8) (16). Both bands were absent in samples containing un-
treated bacteria (lane 9). Complementation of the arcA mutant
(lanes 4 and 5) with a copy of arcA inserted in trans at the xyl
locus in two independent isolates (lanes 6 and 7) decreased
levels of binding to the iC3b MAb back to parental levels
(lanes 2 and 3). As expected, the NT127 parental (lane 3) and
arcA mutant (lane 5) strains containing the empty cloning
vector used in generating the complementing construct exhib-
ited iC3b MAb binding similar to those of their respective
wild-type (lane 2) and arcA mutant (lane 4) derivatives.
arcA modulates mRNA levels of LOS glycosyltransferase
genes. In contrast to results with NTHI (Fig. 1), our previous
studies indicated that the serum resistance of an Rd arcA
mutant did not differ from that of the wild type (77). Because
LOS structures represent major factors in complement evasion
by NTHI, we hypothesized that ArcA may regulate LOS
biosynthesis genes in NT127 that are not present in the Rd
genome. The genome of NT127 (GenBank accession no.
ACSL00000000.1) reveals genes that are absent in Rd and
have 97 to 98% predicted amino acid identity to characterized
LOS glycosyltransferase genes. These include lic2C (26, 30),
lex2A and lex2B (21, 33), and a gene with 98% identity to the
FIG. 1. Role of ArcA in resistance to the bactericidal effects of serum and binding to iC3b. (A and B) The NTHI parent strain NT127V (arcA),
the arcA deletion mutant NTAAV (	arcA), and the arcA-complemented strain NTAAC1 (	arcA, arcA) were grown anaerobically (A) and
aerobically (B) to mid-log phase and exposed to pooled normal human serum (NHS) (Innovative Research) at the indicated concentrations for
30 min, followed by plating on sBHI to enumerate CFU. The survival ratios are plotted as the percentage of CFU obtained from serum-treated/
untreated samples. Survival levels of the arcA mutant differed significantly (*) from those of both the parental and complemented strains at 3%
NHS under anaerobic conditions (P  0.001 and P  0.05, respectively, by one-way analysis of variance [ANOVA] with Bonferroni’s multiple-
comparison test). In all cases, differences between the parent and complemented strains were not statistically significant. No statistically significant
differences were detected among the aerobic samples in panel B. (C) iC3b binding to NT127. Western blots of wild-type NT127, NT127 containing
an empty cloning vector in the xyl locus (NT127V), an arcA deletion mutant (NTAA), and arcA mutant containing an empty vector in xyl (NTAAV),
and two independent isolates containing arcA complemented in trans at the xyl locus (NTAAC1 and NTAAC2) (lanes 2–7, respectively) are shown.
Bacteria grown anaerobically to logarithmic phase were incubated with 5% pooled NHS for 30 min at 37°C. Whole-cell lysates were separated by
NuPAGE (Novex 4 to 12% Bis-Tris) and immunoblotted with anti-iC3b MAb. For a loading control, the bottom third of the same blot is stained
with Coomassie blue. The arrow indicates the iC3b
1 chain. Lane 1 contains molecular size markers, lane 8 contains pure iC3b made from
fluid-phase C3b, and lane 9 contains bacteria incubated in the absence of serum. Relative total densities of the bands in the region between 120
kDa and  67 kDa from lanes 2 to 7 normalized to that of the 40-kDa band from the same corresponding lane in the Coomassie blue-stained
portion of the gel are 0.5, 0.6, 2.1, 1.4, 0.5, and 0.8, respectively.
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predicted glycosyltransferase gene, lic2B (26). To evaluate po-
tential regulation of LOS genes by ArcA, transcriptional anal-
ysis of lic2B, lic2C, and lex2A, genes likely to participate in
modifying the LOS outer core, was done by RT-qPCR in
NT127, its arcA mutant, and the arcA mutant that was com-
plemented with arcA. Figure 2A shows the results obtained
with two independently derived strains of each genotype used
in a total of four independent experiments conducted in par-
allel. The lic2B gene exhibited up to6-fold-decreased expres-
sion in arcA mutant isolates relative to parental or comple-
mented strains (Fig. 2A, left panel). Furthermore, expression
of lic2C, which is located immediately downstream of lic2B,
was also ArcA activated (Fig. 2A, right panel). The lic2C gene
is needed for addition of the proximal glucose residue in an

1-3 linkage to heptose II of the LOS inner core (30). In
contrast, expression levels of lex2A, which is cotranscribed with
lex2B (21), and lgtC (data not shown) did not exhibit regulation
by ArcA. Primer extension analysis mapped a lic2B transcrip-
tional start site to a distance of 26 bp upstream of the puta-
tive lic2B ATG start codon (Fig. 2B). Located 87 bp upstream
of the start site is a potential ArcA binding site with an 8/10
match to the 10-bp consensus binding site of E. coli (5[A/T]
GTTAATTA[A/T]3), consistent with transcriptional activa-
tion by ArcA (39). Promoter regions for lic2B were compared
among available NTHI genome sequences by ClustalW align-
ment. Of the 18 NTHI strains for which partial or complete
genome sequences are available, 8 strains contain single copies
of lic2B with 96 to 100% predicted amino acid identity to Lic2B
of NT127. The lic2B promoter regions were 95 to 96% iden-
tical between strains, and the 10-bp ArcA motif and its position
relative to 10/35 promoter consensus sequences were iden-
tical in all eight NTHI strains and in Hib.
lic2B and lic2C mutants exhibit decreased serum resistance.
Because arcA is required for serum resistance in NT127 and
was observed to regulate the expression of lic2B and lic2C, we
examined the roles of these genes in serum resistance. Nonpolar
deletion mutations precisely removing the complete open read-
ing frames of lic2B or lic2C were generated in strain NT127. In
serum bactericidal assays conducted with cultures grown an-
aerobically, with two independently derived clones for each
mutation, lic2B and lic2C mutants yielded marked and statis-
tically significant decreases in survival compared to the wild
type, reaching differences in 3% NHS of 9-fold and 14-fold
between the wild type and the lic2B and lic2C mutants, respec-
tively (Fig. 3A). In contrast, nonpolar deletion of the lex2A
gene, which is not regulated by ArcA and is thought to be
required for addition of the second -glucose residue extend-
ing from Hep I of the inner core (21), did not confer an
appreciable defect in serum resistance (Fig. 3A). Complemen-
tation of the lic2B mutation restored viability of the lic2B
mutant to parental levels (Fig. 3B), reaching marked and sta-
tistically significant differences in 3% and 5% NHS (4-fold
and 80-fold differences between the lic2B mutant and the
parent; equivalent differences were seen between the lic2B
mutant and complemented strain).
To determine whether lic2B is required for serum resistance
in an additional clinical NTHI isolate, we examined this phe-
notype in PittGG, a strain first isolated from the external ear
discharge of a child with otorrhea (7, 66) and for which a draft
genome sequence is available. PittGG was previously shown to
FIG. 2. Levels of lic2B and lic2C mRNAs in the arcA mutant and complemented strains. (A) Expression of lic2B and lic2C was analyzed by
reverse transcriptase quantitative PCR (RT-qPCR) from four independent anaerobic cultures of parental strains NT127 and NT127V (arcA),
arcA deletion mutants, NTAA and NTAAV (	arcA), and arcA-complemented strains NTAAC1 and NTAAC2 (	arcA, arcA). Values for strains
with the same arcA genotypes (NT127/NT127V, NTAAC1/NTAAC2, and NTAA/NTAAV) were combined as replicates. Log-transformed
fluorescence levels of PCR products corresponding to lic2B and lic2C cDNAs normalized to those of rpoA, which encodes the alpha subunit of
RNA polymerase, were significantly different (*) in parent and complemented strains versus the arcA mutant, as indicated below the chart
(one-way ANOVA with Bonferroni’s multiple-comparison test). (B) Transcriptional start site of lic2B. Primer extension analysis was performed
to map the start site of transcription (data not shown). The nucleotide sequence of the 5 region of lic2B is shown below the schematic
representation of the genomic organization of lic2BC. The arrow at the 1 position indicates the start site of transcription for lic2B. The
presumptive ATG initiation codon is underlined. Putative 10 and 35 RNA polymerase promoter consensus sites are boxed. A potential ArcA
binding site is bracketed.
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exhibit a greater degree of virulence than 10 other clinical
NTHI isolates, producing the most rapid and severe local and
systemic disease in a chinchilla model of otitis media (7). In
our serum bactericidal assay PittGG appeared to be more
serum resistant than NT127, and a lic2B mutation in the
PittGG background conferred a marked decrease in this
resistance (15-fold decrease in 20% NHS) compared to the
wild type (Fig. 3C), indicating that a role for lic2B in serum
resistance is not unique to the NT127 strain.
LOS structure of the lic2Bmutant. While the lic2B gene was
postulated to encode a glycosyltransferase of LOS biosynthesis
based on nucleotide sequence similarity to lic2A, a known
glycosyltransferase gene, the biochemical role of lic2B has re-
mained obscure (26). To obtain a more complete understand-
ing of the functional role of lic2B in serum resistance, we
examined the carbohydrate modification that it confers. O-
deacylated LOS was prepared and analyzed by negative-ion
CE-ES-MS to obtain a structural fingerprint (38) (Table 3).
Glycoform composition and linkage analyses for the lic2B mu-
tant were compared to those for wild-type NT127 to ascertain
the structural consequences of the mutation for the LOS.
Sugar composition analysis indicated that the lic2B mutant
LOS was devoid of galactose in its outer core, in contrast to
that of NT127, which exhibited a glucose-to-galactose ratio of
3:1 (Table 4). LPS-OH of the wild-type strain was analyzed
by CE-MS (Table 3), revealing a major triply charged ion at
m/z 812.53 corresponding to a composition of PCho, 3Hep,
2Hex, Kdo-P, PEtn, lipid A-OH. Smaller amounts of both a
glycoform at m/z 758.03 consistent with loss of a hexose res-
idue and larger glycoforms (m/z 866.53, 920.53, and 988.53)
consistent with structures containing additional Hex, 2Hex, or
2Hex, HexNAc glycoforms, respectively, were also observed.
MS analysis of the mutant LPS-OH suggested a composition of
PCho, 3Hep, 2Hex, Kdo-P, PEtn, lipid A-OH as the major
glycoform with smaller amounts of the 1Hex and 3Hex glyco-
forms.
Methylation analysis was performed on the nonfractionated
core OS from the wild-type strain in order to determine the
linkage pattern of the molecule, revealing the presence of
terminal Glc, terminal Gal, 4-substituted Glc, and terminal
FIG. 3. Serum resistance defect of NTHI lic2B and lic2C mutants. Wild-type strains and LOS mutants were grown anaerobically to mid-log
phase and exposed to pooled NHS at the indicated percentages for 30 min, followed by plating to enumerate CFU. Survival ratios are plotted as
the percentage of CFU obtained from serum-treated/untreated samples (A) Wild-type NTHI strain NT127, and deletion mutants NTlic2B,
NTlic2C, and NTlex2A (	lic2B, 	lic2C, and 	lex2A, respectively). Each deletion mutant is represented by isolates obtained from two independent
transformations. Differences were statistically significant (*) between the parent and the lic2B and lic2C mutants at 2% and 3% NHS (mixed-model
ANOVA for repeated measures with Bonferroni’s multiple-comparison test). (B) NTV (lic2B), lic2B deletion mutant, NTlic2BV (	lic2B), and
lic2B-complemented strain NTlic2BComp (	lic2B, lic2B). The lic2B mutant exhibited a statistically significant decrease in survival (*) compared
to both the parental and complemented strains at 2%, 3%, and 5% NHS. Statistical significance for panels B and C was evaluated by one-way
ANOVA with Bonferroni’s multiple-comparison test. (C) Wild-type NTHI strain PittGG and lic2B deletion mutant PittGGlic2B (	lic2B),
represented by isolates from three independent transformations. Differences were statistically significant (*) between the parent and the lic2B
mutant at 10% and 20% NHS.
TABLE 3. Negative-ion CE-ES-MS data and proposed compositions of O-deacylated LPS (LPS-OH) from wild-type NT127 and lic2B mutant
strain NTlic2B (	lic2B)
Strain
Observed ions (m/z) Molecular mass (Da) Relative
intensity Proposed composition(M  2H)2 (M  3H)3 Observed Calculateda
NT127 1,137.5 758.0 2,277.0 2,278.9 0.3 PCho, Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,219.0 812.5 2,440.3 2,441.0 1.0 PCho, 2Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,300.0 866.5 2,602.3 2,603.2 0.6 PCho, 3Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,381.0 920.5 2,764.3 2,765.3 0.2 PCho, 4Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,483.5 988.5 2,968.7 2,968.5 0.1 PCho, HexNAc, 4Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
	lic2B mutant 1,137.5 758.0 2,277.0 2,278.9 0.4 PCho, Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,218.5 812.0 2,439.0 2,441.0 1.0 PCho, 2Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
1,300.0 866.5 2,602.3 2,603.2 0.1 PCho, 3Hex, 3Hep, PEtn, Kdo-P, lipid A-OH
a Average mass units were used for calculation of molecular mass based on the proposed composition as follows: O-deacylated lipid A (lipid A-OH), 952.00;
N-acetylhexosamine (HexNAc), 203.19; hexose (Hex), 162.15; heptose (Hep), 192.17; 2-keto-3-deoxyoctulosonic acid phosphate (Kdo-P), 300.13; phosphoethanolamine
(PEtn), 123.05; phosphorylcholine (PCho), 165.05.
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LD-Hep in an approximate ratio of 1:1:2:1. Trace amounts of
4-substituted and 3-substituted Gal were also observed (Table
5). Conversely, for the lic2B mutant, methylation analysis on
the nonfractionated core OS revealed only terminal Glc, 4-sub-
stituted Glc, and terminal LD-Hep in an approximate ratio of
2:1:1. Linkage analysis in combination with the compositional
and mass spectrometry analyses therefore suggested that, in
comparison to the parent LOS, the mutant elaborates a
truncated molecule lacking a galactose residue, presumably
4-linked to a glucose residue.
In order to elucidate the precise locations and linkage pat-
terns of the OS from the wild-type and mutant strains, NMR
studies were performed on the OS fraction that gave the most
resolved and homogeneous spectrum. The assignment of 1H
resonances of the inner core oligosaccharides for each strain
were achieved by correlation spectroscopy (COSY), total cor-
relation spectroscopy (TOCSY), and nuclear Overhauser ef-
fect spectroscopy (NOESY) experiments with reference to the
published data for the structurally related oligosaccharides
from H. influenzae strains Eagan (47), Rd (62), and SB33 (10)
and revealed that the conserved inner core structure (Hep I-III
and Glc I) was present. Similarly, the assignment of 13C reso-
nances of the samples was achieved by virtue of 13C-1H het-
eronuclear single-quantum correlation (HSQC) and 13C-1H
HSQC-TOCSY experiments (data not shown). Apart from the
conserved inner core residues (data not shown), an anomeric
proton was observed for an 
-glucose residue at 5.28 ppm in
both the wild-type and lic2B mutant core OS (Table 6). The
chemical shifts for the spin systems of this residue in these two
strain backgrounds suggested that for the mutant strain the

-glucose residue was not substituted, whereas in the parent
strain it appeared to be 4-substituted. An inter-NOE connec-
tivity from the anomeric proton of this glucose residue to a
resonance at 4.07 ppm was identified. This resonance was as-
signed as the proton at the 3 position of the Hep II residue by
virtue of 13C-1H HSQC and 13C-1H HSQC-TOCSY experi-
ments (data not shown). Furthermore a -galactose residue
was identified in only the parent strain core OS, based on
characteristic spin systems in TOCSY experiments, with H-1
(4.48 ppm), H-2 (3.55 ppm), H-3 (3.67 ppm), and H-4 (3.92
ppm) resonances being identified (Table 6). An inter-NOE
connectivity from the anomeric proton of this galactose residue
to a resonance at 3.74 ppm was identified. This resonance was
assigned as the proton at the 4 position of the 
-glucose resi-
due by virtue of 13C-1H HSQC and 13C-1H HSQC-TOCSY
experiments (data not shown). This assignment is also consis-
tent with the methylation analysis data, which identified a
4-linked Glc residue and a terminal galactose residue in the
wild-type strain. Together these data are consistent with lic2B-
dependent addition of a -galactose at position 4 of the 
-glu-
cose extension on Hep II. A model of the NT127 and lic2B
mutant LOS is depicted in Fig. 4.
lic2B is required for NTHI survival in a mouse model of
bacteremia. Because an arcA mutation confers survival and
virulence defects in the murine bloodstream (12, 77), we tested
whether lic2B was also required in vascular infection in mice.
Wild-type NT127 was compared to three independently gen-
erated lic2B mutants. After intraperitoneal inoculation, bacte-
ria were recovered at similar levels from blood at 4 h for both
the wild type and the lic2B mutants. At subsequent times,
marked differences were observed. At 8 h postinoculation the
CFU recovered for the lic2B mutants had declined significantly
(83-fold; P  0.01) compared to that recovered for the wild
type, and at 22 h postinoculation they differed by at least
12-fold, a trend consistent with the 8-h results (Fig. 5).
Role of Lic2B in resistance to the classical pathway of com-
plement. H. influenzae surface structures, including LOS and
outer membrane proteins, have been implicated in diverse
mechanisms of complement resistance that are not fully un-
derstood (24). Therefore, it was of interest to investigate the
influence of lic2B on NTHI interactions with elements of the
complement system. The majority of the bactericidal effect of
serum on H. influenzae in vitro requires activity of the classical
pathway (73). The classical pathway is initiated by the C1
complex (C1q, C1r, and C1s), a component specific to this
pathway with C1q binding to a variety of targets, including
antigen-antibody complexes on the pathogen surface, to initi-
ate the stepwise cascade of complement activation (71). To
determine if the lic2B-dependent modification of the LOS
confers resistance to the classical pathway, we tested the bac-
tericidal effect of C1q-depleted human serum on the lic2B
mutant. Viability of the lic2B mutant was similar to that of the
wild-type strain in C1q-depleted human serum, and supple-
mentation with human C1q protein restored killing of the
mutant to a greater degree than for the wild type, whose
survival was at least 146-fold that of the mutant (Fig. 6A). This
result indicated a specific role for the classical pathway in
killing the lic2B mutant in complement-dependent bactericidal
assays.
Additional support for this conclusion was obtained by ex-
amining the viability of the lic2B mutant in bactericidal assays
with NHS containing EGTA and MgCl2, which selectively
blocks the classical and mannose binding lectin pathways but
not the alternative pathway (Fig. 6B and C). In the absence of
EGTA/MgCl2, we observed 60% killing of the lic2B mutant
at 2% NHS, over 90% killing of the mutant at 3% NHS, and no
appreciable killing of the wild type at either concentration
TABLE 5. Glycosyl linkage analysis of core oligosaccharide from
NT127 and NTlic2B (	lic2B)
Strain
Relative abundancea
t-Glc t-Gal 4-Glc 4-Gal 3-Gal t-LD-Hep
NT127 1 1 2 tr tr 1
	lic2B mutant 2 1 1
a Relative abundances of sugars from methylation linkage analysis in GLC
profiles. t, terminal; 4-, 4-linked; 3-, 3-linked.
TABLE 4. Sugar analysis of LOS from NT127 and
NTlic2B (	lic2B)
Strain
Relative abundancea
Glc Gal GlcNAc LD-Hep
NT127 3 1 1 2
	lic2B mutant 3 0 1 2
a Relative abundances of sugars from GLC profiles. Glc, glucose; Gal, galac-
tose; GlcNAc, N-acetylglucosamine (from lipid A region); LD-Hep, L-glycero-
D-manno-heptose.
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(0% and 10%, respectively). In contrast, blocking both the
classical and lectin pathways resulted in no killing of the lic2B
mutant in concentrations of serum ranging from 2% (Fig. 6B)
to as high as 80% (Fig. 6C). No decrease in viability was seen
with control cultures treated with heat-inactivated serum in the
absence or presence of EGTA and MgCl2. These results along
with the C1q-dependent killing data confirm that the classical
pathway is required for complement-dependent killing of the
lic2B mutant; the alternative pathway alone cannot mediate
killing of the lic2B mutant. Moreover, the requirement for C1q
in killing suggests that the mannose binding lectin pathway is
not involved in bactericidal activity against NTHI.
The contribution of the lic2B gene in resisting the classical
pathway of complement may occur at a variety of steps, includ-
ing antibody binding, C1 engagement, C4 activation, C4b de-
position, or C4b inactivation. To begin to address the step at
which classical complement components are influenced by
lic2B, we evaluated total binding of C3, C4, and serum anti-
bodies (IgG and IgM) to the NT127 parent, lic2B mutant, and
complemented strain (Fig. 6D). As observed with the arcA
mutant, the lic2B mutant bound increased levels of C3 and C4
compared to the parent strain. Complementation reduced de-
position of C3 and C4 to levels similar to those seen with the
parental strain. We did not detect a difference in interaction
with IgG and IgM between the two strains, suggesting that
differences in the amount of antibody binding do not account
for the serum resistance or differences in complement C4 or
C3 deposition. These results suggest that the lic2B-encoded
LOS structure confers complement resistance by interfering
with the classical complement pathway at a step after antibody
binding but at or preceding C4b deposition.
DISCUSSION
The results of this study provide insight into two previously
unresolved aspects of H. influenzae pathogenesis. First, the
redox-responsive regulatory protein ArcA was previously im-
plicated in serum resistance and virulence of H. influenzae;
however, the ArcA-regulated genes or factors that could ac-
count for either of these phenotypes were unknown. Second,
the lic2B gene was considered likely to contribute to the patho-
genic properties of NTHI strains based on epidemiological
data, yet the molecular function of lic2B and the mechanism by
which it may participate in virulence had not been defined. In
FIG. 4. Structural models of LOS from NTHI wild-type NT127
(A) versus the lic2B mutant NTlic2B (	lic2B) (B), in which a galactose
extension from Hep II is absent. Glc, glucose; Gal, galactose; Hep,
heptose; Kdo, 2-keto-3-deoxyoctulosonic acid; PPEtn, pyrophospho-
ethanolamine, PEtn, phosphoethanolamine; GalNAc, N-acetylgalac-
tosamine; Neu5Ac, sialic acid; PCho, phosphorylcholine. The LOS
structure is based on analysis of O-deacylated LOS. R groups repre-
sent LOS extensions inferred based on the presence of the lic2A, lic3A,
lgtC, and lgtD genes in the NT127 genome. All of the genes specifying
R groups except lgtD are subject to phase variation, and the structures
they are predicted to add were below the detectable limits of the mass
spectrometry analysis.
FIG. 5. Persistence defect of the H. influenzae lic2B mutant in a
mouse model of bacteremia. NTHI wild-type NT127 and lic2B mutant
NTlic2B (	lic2B) were inoculated i.p. at a dose of 108 CFU into
4-week-old C57BL/6 mice, and blood was sampled at 4, 8, and 22 h
postinoculation for CFU determination. Bars represent the average
CFU/l. *, statistically significant (P  0.01 by the Kruskal-Wallis test
with Dunn’s multiple comparison test). LLD, lower limit of detection.
TABLE 6. 1H and 13C NMR chemical shifts for the core OS from wild-type NT127 (WT) and lic2B mutant strain NTlic2B (	lic2B)
Strain Residue
Chemical shifta NOE
H-1 (C-1) H-2 (C-2) H-3 (C-3) H-4 (C-4) H-5 (C-5) H-6 (C-6) H-7 (C-7) Interconnectivity Intraconnectivity
WT and 	lic2B
mutant
Hep II 5.83 (99.5) 4.28 (79.4) 4.07 (77.4) ND ND 4.58 (74.6) 3.90,
3.77 (60.4)
4.00 Hep I H-3 4.28 H-2
WT 
-Glc 5.28 (100.6) 3.60 (71.8) 3.89 (70.7) 3.74 (78.1) ND ND 4.07 Hep II H-3 3.60 H-2
	lic2B mutant 
-Glc 5.28 (100.9) 3.55 (71.9) 3.77 (72.8) 3.52 (69.3) ND ND 4.07 Hep II H-3 3.55 H-2
WT -Gal 4.48 (104.5) 3.55 (71.1) 3.67 (72.6) 3.92 (69.7) ND ND 3.74 
-Glc H-4 3.67 H-3
a Data were recorded at 25°C relative to internal acetone at 2.225 ppm for the 1H shifts and at 31.07 ppm for the 13C shifts. ND, not determined.
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this report we demonstrate that ArcA positively regulates tran-
scription of lic2B, which we determined to be responsible for a
galactose addition to the LOS outer core and serum resistance
in NTHI. Consistent with its role in resistance to serum com-
plement, lic2B promotes survival of NTHI in the mammalian
bloodstream. Complement has been implicated in host defense
in other sites of disease, such as the middle ear during infec-
tious otitis media or during lung inflammation (16, 17, 59, 72,
74). Therefore, these results indicate a potential mechanism
whereby strains expressing lic2B may exhibit enhanced viru-
lence in the human host.
Signal transduction in response to environmental cues is
used by bacterial pathogens to appropriately coordinate gene
expression during stages of colonization or pathogenesis. For
obligate pathogens such as H. influenzae that have evolved to
grow exclusively within the mammalian host, an economical
strategy would be to coordinately control physiological adap-
tations together with virulence-associated responses. The
ArcAB signal transduction system appears to mediate both of
these types of responses. In H. influenzae ArcAB senses
changes in intracellular redox status as bacteria transit between
conditions of high and low oxygen, mediating control over
diverse genes of respiration and stress resistance (19, 77), The
current study shows that ArcA also activates LOS biosynthesis
genes, including lic2B (Fig. 2), which is required for serum
resistance (Fig. 3) and NTHI survival in the bloodstream
model (Fig. 5). The niche in which ArcA may function during
natural infection is not known; however, ArcA-mediated
activation of the virulence gene lic2B suggests that NTHI
encounters a low-oxygen environment leading to ArcA ac-
tivity at some point during colonization or pathogenesis in
which lic2B is required.
The lic2B gene has been thought to be a glycosyltransferase
for many years; however, its biochemical function and poten-
tial role in virulence have remained inferential in that loss of
the gene is associated with LOS truncation (26), but the precise
contribution of lic2B to the structure was not known (46). Its
distribution in clinical isolates suggested that lic2B may con-
tribute to disease, as Pettigrew and colleagues found it to be
present more frequently among 48 middle ear isolates of NTHI
than among 46 nasopharyngeal and throat isolates in healthy
children, suggesting a potential importance of lic2B in otitis
media (56). However, a study of 72 isolates by Erwin and
colleagues did not reveal an increased prevalence of lic2B in
invasive isolates (15). It is likely that numerous genes contrib-
ute to pathogenesis of genetically distinct strains at different
sites of infection, and more complete knowledge of each gene’s
relative mechanistic contribution to pathogenesis is necessary
FIG. 6. Killing of the lic2B mutant is dependent on the classical complement pathway. (A) Viability of the lic2B mutant versus wild-type NT127
in C1q-depleted human serum. Wild-type NT127 (WT) and NTlic2B (	lic2B) were exposed to C1q-depleted human serum at the indicated
concentrations with or without supplementation with 5 g of C1q human protein for 30 min. The survival ratios are plotted as the percentage of
CFU obtained from serum-treated/untreated samples, with statistical significance evaluated by one-way ANOVA with Bonferroni’s multiple-
comparison test. Differences were statistically significant (*) between the WT and the lic2B mutant at 4% C1q-depleted serum supplemented with
C1q protein (P  0.05; n  3 independent cultures). (B and C) Wild-type NT127 (WT) and NTlic2B (	lic2B) were exposed to pooled NHS in
the absence or presence of EGTA and MgCl2 at different dosages for 30 min. Survival ratios were analyzed as described for panel A. Differences
were statistically significant (*) between the WT and the lic2B mutant at 2% and 3% serum (P  0.001; n  3 independent cultures). (D) Serum
sensitivity of the lic2B mutant correlates with increases in C3 and C4 binding and is independent of antibody binding. A total of 108 CFU/ml of
parental strain NTV (lic2B), lic2B deletion mutant NTlic2BV (	lic2B), and lic2B-complemented strain NTlic2BComp (	lic2B, lic2B) were
added to 5% pooled NHS and incubated at 37°C for 30 min, followed by detection with FITC-conjugated antibodies specific to C3c, C4, IgM, and
IgG. Bound antibodies were detected using flow cytometry. Median fluorescences for C3 binding were 5, 96, 224, and 64 for the control, parent,
lic2B mutant, and complemented strain, respectively; those for C4 binding were 6, 18, 39, and 16, respectively. An independent repetition of the
C3 and C4 binding experiments yielded similar results (data not shown).
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to evaluate the significance of such clinical correlations. Our
results demonstrate lic2B-dependent addition of a galactose
extension from the glucose residue on the penultimate heptose
(Hep II) of the LOS in strain NT127. Based on previous
studies, the glucose on Hep II is likely added by lic2C (30), the
gene immediately downstream of lic2B in a probable operon.
The lic2B mutant also appeared to be deficient in a minor
N-acetylhexose moiety, which likely represents a terminal N-
acetylgalactosamine added by the product of lgtD (28). Al-
though the lack of this structure in the lic2B mutant could
result from difficulty in detecting less-abundant species in the
mass spectrometry analysis, it is also possible that addition of
N-acetylgalactosamine requires the galactose residue added by
lic2B. Sialic acid can also be added to the LOS and may depend
on lic2B; however, the medium for these experiments was not
supplemented with the precursor required for sialylation of
NTHI, CMP-N-acetylneuraminic acid, and sialic acid was not
detected by our structural analysis of NT127. Therefore,
although N-acetylgalactosamine and sialic acid have been
implicated in serum resistance, lic2B appears to be capable
of mediating serum resistance independently of these distal
structures. Nevertheless, our results do not rule out the possi-
bility that during infection lic2B exerts some of its effects via
these structures, and it will be of interest to evaluate the po-
tential importance of lic2B in generating the scaffold for addi-
tional LOS modifications that influence virulence.
Resistance to complement-mediated killing mediated by
lic2B provides a mechanism that may account for the associa-
tion between the presence of this gene and increased severity
of otitis media, and it likely contributes to lung pathogenesis as
well. Active complement is found in effusions isolated from
patients with otitis media (53), and complement has been im-
plicated as playing a role in defense against NTHI in the
middle ear in a chinchilla model of otitis media (16). Comple-
ment is also likely to play a role in the context of inflammation
in the lung. Although the healthy lung does not appear to
contain abundant levels of serum complement factors, disease
states such as chronic obstructive pulmonary disease (COPD)
or infection with influenza virus, both predisposing conditions
that are exacerbated by subsequent H. influenzae infection,
have been shown to result in increased levels of complement
proteins in the lung (5, 45). In addition to their roles in the lytic
pathway, complement components C1q, C3b, and C4b act as
opsonins that can bind and target bacteria for destruction by
phagocytes (61). Our results in Fig. 6 indicate that, relative to
the wild type, the lic2B mutant bound more readily to comple-
ment components C3 and C4, and the presence of the C1q
protein, the initiator of the classical complement pathway, was
required for the bactericidal effect, indicating involvement of
this complement factor in killing of the lic2B mutant in our
serum bactericidal assays. Therefore, the ability of NTHI to
inhibit binding of C1q or subsequent interactions with other
complement proteins could protect the pathogen from recog-
nition and killing by mucosal phagocytes, and it will be of
interest to determine whether lic2B may contribute to respira-
tory tract infection by inhibiting such interactions.
Overall, the results of our study indicate a role for the
redox-responsive regulator ArcA in positive control of NTHI
LOS biosynthesis genes that are required for serum resistance
and invasive infection. ArcA-deficient mutants of other bacte-
rial pathogens such as Vibrio cholerae, a diarrheal pathogen of
humans, and Actinobacillus pleuropneumoniae, the causative
agent of porcine pleuropneumonias, also exhibit reduced vir-
ulence in animal models (8, 64) by mechanisms that remain to
be established. Our results raise the possibility that ArcA-
mediated regulation of LPS structure in these bacteria could
play a role in their pathogenesis. Control of diverse LPS mod-
ifications by signal transduction systems has been observed in
numerous bacterial pathogens. The structures that are regu-
lated and their control mechanisms vary extensively between
species (22). In H. influenzae, regulators have been identified
for LOS sialic acid modification, which is controlled by the
cyclic AMP (cAMP)-responsive cAMP receptor protein (CRP)
in conjunction with a response to substrate availability by SiaR
(34, 35, 36). Several studies have revealed regulation of LOS or
LPS outer core glycosyltransferase activity in other species (27,
69, 70); however, connections between specific signaling pro-
teins and the regulated glycosyltransferase genes are not well
understood. The discovery of ArcA-mediated regulation of
LOS glycosyltransferase genes reveals a new area for investi-
gation of bacterial signaling during infection, and it will be of
interest to determine whether other virulence factors are sim-
ilarly controlled in NTHI and other pathogens. Coordinate
regulation of classical virulence factors such as LOS structure,
as shown in this report, with physiological responses to redox
conditions by NTHI highlights a mechanism by which this
persistent colonizer of the human respiratory tract can effi-
ciently orchestrate molecular interactions critical for infection.
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